The Development and Use of Hybrid MR-PET Imaging in Molecular Science
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: closed (30 April 2022) | Viewed by 462
Special Issue Editors
Interests: ultra-high field MRI; hybrid MR-PET; metabolic imaging; non-proton imaging; quantitative MRI; MRI sequence development
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Positron emission tomography (PET) is a widely used in vivo imaging modality employed to measure numerous molecular targets in the brain, including glucose metabolism, oxygen usage, and neurotransmitter distribution and concentration. However, although PET provides an unmatched ability to image numerous biochemical and molecular targets, its ability to capture detailed spatial and anatomical information is limited. In contrast, magnetic resonance imaging (MRI) excels in capturing even very small changes in brain structure and function. Thus, the complementary nature of the two modalities makes integration in a simultaneous system highly desirable for both clinical and research applications.
For this Special Issue, we aim to highlight the importance of hybrid MR-PET imaging, detailing methods and applications in human disease. We will also give an overview of current human research, with a particular focus on applications in neuroimaging and cognitive neuroscience or others.
Prof. Dr. N. Jon Shah
Dr. Christoph Lerche
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
